Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic HBV Infection (HBeAg Negative)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01521975
What this trial is testing

A Two-year Study of Telbivudine in HBeAg Negative Hepatitis

Who this might be right for
Hepatitis B, Chronic
Third Affiliated Hospital, Sun Yat-Sen University 360
Post-approval studies (Phase 4)Study completedNCT00393484
What this trial is testing

A Study in Korea of Entecavir Versus Lamivudine in Adults With Chronic Hepatitis B Infection

Who this might be right for
Chronic Hepatitis B
Bristol-Myers Squibb 122
Not applicableStudy completedNCT01667432
What this trial is testing

An Observational Study of Peginterferon Alfa-2a (PEGASYS®) in Patients With HBeAg Positive or HBeAg Negative Chronic Hepatitis B

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 141
Large-scale testing (Phase 3)UnknownNCT01172392
What this trial is testing

Study to Assess the Loss of HbsAg After a 48-week Treatment Period With Pegylated Interferon Alpha 2a in Patients With Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis BAgHbs Negativation
ANRS, Emerging Infectious Diseases 185
Large-scale testing (Phase 3)Ended earlyNCT02058108
What this trial is testing

Study of Efficacy and Safety, Tolerability and Pharmacokinetics of Telbivudine in Children and Adolescents With Compensated Chronic Hepatitis B Virus Infection

Who this might be right for
Chronic Hepatitis B
Novartis Pharmaceuticals 53
Testing effectiveness (Phase 2)Looking for participantsNCT07069569
What this trial is testing

Study of AHB-137 Injection Combined With Other Hepatitis B Drugs

Who this might be right for
Chronic Hepatitis B
Ausper Biopharma Co., Ltd. 200
Early research (Phase 1)Study completedNCT02496897
What this trial is testing

Phase I Safety and Immunogenicity of FP-02.2 in Chronic Hepatitis B

Who this might be right for
Hepatitis B
Altimmune, Inc. 61
Testing effectiveness (Phase 2)Study completedNCT05839639
What this trial is testing

Evaluate the Antiviral Activity and Safety of HH-003 Injection in Subjects With HBeAg-Negative Chronic Hepatitis B Treated With Nucleos(t)Ide Reverse Transcriptase Inhibitors

Who this might be right for
Chronic Hepatitis B
Huahui Health 73
Post-approval studies (Phase 4)WithdrawnNCT01179594
What this trial is testing

48 Versus 96 Weeks of Peginterferon Alfa-2a [Pegasys] Treatment, With or Without Entecavir, in Patients With Chronic Hepatitis B.

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche
Post-approval studies (Phase 4)UnknownNCT02365402
What this trial is testing

Efficacies of Entecavir Add on HBeAg Negative Patients With HBV DNA Positive During Peginterferon Alpha 2a Treatment

Who this might be right for
Chronic Hepatitis B
Beijing Ditan Hospital 180
Large-scale testing (Phase 3)Study completedNCT01697501
What this trial is testing

A Study Evaluating IL28B Polymorphism in Patients With HBeAg-Negative Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a) in Study ML18253

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 88
Post-approval studies (Phase 4)Study completedNCT04782375
What this trial is testing

Safely Discontinue Antiviral Treatment in Patients With Chronic Hepatitis B

Who this might be right for
Hepatitis B, Chronic
Asan Medical Center 140
Testing effectiveness (Phase 2)Study completedNCT06115993
What this trial is testing

Evaluate the Safety and Efficacy of AHB-137 in Healthy Participants and HBeAg-negative Chronic Hepatitis B (CHB) Patients

Who this might be right for
Hepatitis B, Chronic
Ausper Biopharma Co., Ltd. 129
Not applicableStudy completedNCT01283074
What this trial is testing

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HbeAg-negative Chronic Hepatitis B (Perseas)

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 107
Testing effectiveness (Phase 2)Study completedNCT03905655
What this trial is testing

Study of Nitazoxanide Compared to Placebo in Subjects With HBeAG-Negative Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Romark Laboratories L.C. 51
Large-scale testing (Phase 3)Study completedNCT02249988
What this trial is testing

Clinical Efficacy of ABX203 Therapeutic Vaccine in HBeAg Negative Patients With Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Abivax S.A. 261
Large-scale testing (Phase 3)Ended earlyNCT00823342
What this trial is testing

ANRS HB 05 Multicenter Study Evaluating Efficacy and Safety of Clevudine Monotherapy Versus Tenofovir Monotherapy Versus Combination Therapy of Clevudine and Tenofovir for 96 Weeks in HBeAg Negative Patients With Chronic Hepatitis B, naïve to Anti-VHB Therapy

Who this might be right for
HBe Negative Chronic Hepatitis BHepatitis B Viral Infection
French National Agency for Research on AIDS and Viral Hepatitis 150
Not applicableStudy completedNCT00973219
What this trial is testing

Hepatitis B Surface Antigen(HBsAg) Loss in Chronic Hepatitis B Patients With Low Viral Load

Who this might be right for
Chronic Hepatitis B
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 151
Large-scale testing (Phase 3)Ended earlyNCT00496158
What this trial is testing

Efficacy and Safety of Clevudine Compared With Adefovir in Patients With Chronic Hepatitis Due to Hepatitis B Virus

Who this might be right for
Chronic HepatitisHepatitis B
Pharmasset
Early research (Phase 1)Study completedNCT06744686
What this trial is testing

Phase 1 Study of HT-102 Administered Subcustaneously in Healthy Participants and Patients with Chronic Hepatitis B for Safety, Tolerability, Pharmacokinetics (PK), and Antiviral Activity (only in Participants with Chronic HBV Infection)

Who this might be right for
Chronic Hepatitis B
Suzhou HepaThera Biotech Co., Ltd. 56
Next Page